Form D · Pharmaceuticals

Galera Therapeutics LLC

St. Louis, MO · CIK 0001492474

Offering snapshot reported Sep 27, 2011 · SEC filing

Reported sold: $405K
Investors reported: 1
Minimum accepted: $0
First sale: Mar 21, 2011

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$205,000 → $405,000

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Sep 27, 2011	Amendment	$405,000	$200,000vs Apr 5, 2011	1	SEC filing
Apr 5, 2011	Initial	$205,000	No comparison	1	SEC filing
Jan 31, 2011	Amendment	$805,000	$125,000vs May 25, 2010	8	SEC filing
May 25, 2010	Initial	$680,000	No comparison	3	SEC filing

Offering details

Securities: Debt, Security to be acquired
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-157856

Source: Form D, filed Sep 27, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Robert A. Beardsley	Director, Executive
Phillip Buckler	Executive
Robert Calcaterra	Director
Eric Gulve	Director
Jeffery Keene	Executive
Catherine L. Matthes	Executive
Dennis Riley	Executive
Randy W. Weiss	Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

4041 Forest Park Avenue
St. Louis, MO, 63108